die ängstlichen nehmen ihre gewinne mit. mein tipp für heute 0.39$
Anzeige
Meldung des Tages: Der Countdown zu einer der heißesten Gold-Stories 2026 hat begonnen
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
... 165 166 168 169 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter ... 165 166 168 169 ...
Calypte und die Zeit nach AIDS2004 in Bangkok
WerbungPassende Knock-Outs auf Lufthansa AG
| Strategie | Hebel | |||
| Steigender Lufthansa AG-Kurs | 4,80 | 9,64 | 19,07 | |
| Fallender Lufthansa AG-Kurs | 4,74 | 10,75 | 15,55 | |
Den Basisprospekt sowie die Endgültigen Bedingungen finden Sie jeweils hier: DE000NB4AXC1
, DE000NB4MLS7
, DE000NB4ZP95
, DE000NG6PT25
, DE000NG6YFD6
, DE000NG6Y7T5
. Bitte informieren Sie sich vor Erwerb ausführlich über Funktionsweise und Risiken der Produkte. Bitte beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Beiträge:
5.057
Zugriffe: 255.142 / Heute: 12
Zugriffe: 255.142 / Heute: 12
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +84,90%
Xtrackers Spain UCITS ETF 1D
Perf. 12M: +57,05%
Xtrackers Spain UCITS ETF 1C
Perf. 12M: +56,92%
Xtrackers ATX UCITS ETF 1C
Perf. 12M: +53,93%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +53,84%
über 0,40$ zu halten...
mein tipp: sk bei 0,37$
zu augrid: falsch fomuliert! der hype kommt nicht, weil neue aktien ausgeschüttet wurden, sondern er kommt, um neue investoren zu ködern, die dann zukünftig neue aktien schlucken müssen...
mein tipp: sk bei 0,37$
zu augrid: falsch fomuliert! der hype kommt nicht, weil neue aktien ausgeschüttet wurden, sondern er kommt, um neue investoren zu ködern, die dann zukünftig neue aktien schlucken müssen...
Time & Sales most recent next page
Rec. Time Action Price Volume
11:03:18 AM Bid 0.36 23500
11:01:04 AM Bid 0.36 7300
11:01:00 AM Ask 0.37 17100
11:00:36 AM Ask 0.38 50000
11:00:36 AM Ask 0.37 3000
11:00:28 AM Trade 0.36 30000
11:00:28 AM Bid 0.36 10000
10:58:48 AM Bid 0.36 31300
10:58:06 AM Ask 0.37 6000
10:58:06 AM Ask 0.37 3000
10:58:06 AM Trade 0.37 4000
10:58:06 AM Bid 0.36 10000
10:58:02 AM Trade 0.37 1600
10:58:02 AM Bid 0.37 4000
Rec. Time Action Price Volume
11:03:18 AM Bid 0.36 23500
11:01:04 AM Bid 0.36 7300
11:01:00 AM Ask 0.37 17100
11:00:36 AM Ask 0.38 50000
11:00:36 AM Ask 0.37 3000
11:00:28 AM Trade 0.36 30000
11:00:28 AM Bid 0.36 10000
10:58:48 AM Bid 0.36 31300
10:58:06 AM Ask 0.37 6000
10:58:06 AM Ask 0.37 3000
10:58:06 AM Trade 0.37 4000
10:58:06 AM Bid 0.36 10000
10:58:02 AM Trade 0.37 1600
10:58:02 AM Bid 0.37 4000
auseinandersetzen, den sie schreiben anstatt immer neue IS´s aufzumachen. die sperrung erfolgt immer schneller:
Forumsprofil und Funktionen für "wiederda"
Statistik
Registriert seit 15.02.05 11:30
Status gesperrt
Anzahl Postings 7
Region (PLZ)
leo, arrangiere dich mal mit den mods, dann kannst du auch wieder unbehelligt posten. so aber wird das nichts mehr.
Forumsprofil und Funktionen für "wiederda"
Statistik
Registriert seit 15.02.05 11:30
Status gesperrt
Anzahl Postings 7
Region (PLZ)
leo, arrangiere dich mal mit den mods, dann kannst du auch wieder unbehelligt posten. so aber wird das nichts mehr.
Da hat wohl schon jemand an den nächsten big News geschnuppert, oder weshalb kauft man
shares für knapp 500000 $ !?
After Hours Trade Reporting Thursday February 17
After Hours
Last: $0.36 After Hours
Best Bid: N/A After Hours
High: $0.36
After Hours
Volume: 1,388,500 After Hours
Best Ask: N/A After Hours
Low: $0.36
After Hours
Time (ET) After Hours
Price After Hours
Share Volume
17.32 $ 0.36 1388500
shares für knapp 500000 $ !?
After Hours Trade Reporting Thursday February 17
After Hours
Last: $0.36 After Hours
Best Bid: N/A After Hours
High: $0.36
After Hours
Volume: 1,388,500 After Hours
Best Ask: N/A After Hours
Low: $0.36
After Hours
Time (ET) After Hours
Price After Hours
Share Volume
17.32 $ 0.36 1388500
quotes.nasdaq.com/...=frameset&page=afterhours&symbol=HIV&symb ol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&selected=hiv &FormType=&kind=&Leap=&mkttype=after&sel=afterhours&userinput=
Sorry it took so long to respond. I was gone for part of the day.
In regard to your first statement about written info from someone knowledgeable: No one knows Calypte better than Dr. George and Rick Brounstein. Although it's unlikely that any of us could talk directly to them. You can however check Calypte’s website and read the latest filings and news articles. I find the NR’s very informative. Plus you can listen to Conference Calls when available. I still have some of the transcripts from the most recent CC’s, they are some of the most valuable sources for me. I try to post these when someone mentions a subject that Dr. George covered, such as your question today.
Another source of info that I recommend is from readssthe10qs. I know that is going to shock some people here because most of his posts are quite negative. The reason I read his posts is because sometimes my perspective is too one sided. He knows the history of Calypte and especially its former Chairman of the Board, Tony Cataldo. As an example of why I like to read his posts - there was a question from “umpujv” #2653 about HIV’s cumulative debt. Because readssthe10qs posts are usually negative you know that if Calypte had any debt he would have found it.
As a word of caution: The yahoo board can get ugly at times so you have to let some of it roll off your back otherwise you can get cynical.
As far as the prediction of .05 cent/share: No one from the Company as far as I know has ever made that statement. The information from the CC in my post was an estimate for when the Company might be profitable. They came to that conclusion by using minimal penetration rates in China and Africa. Those sales are contingent upon government approvals.
You also mentioned production of rapid tests starting soon. Dr. George said in the November CC…
“The SFDA, because we are considered to be a Chinese company, due to our Joint Ventures, will give us what is called the “Green Light Pass” through the regulatory process. On this path, they have a regulatory requirement to respond to our application in 90 days. We’ve padded that a little, but just to give us some cushion. We are predicting that we will have an answer from the SFDA by July 1st of 2005.”
So, first the clinical results, second, SFDA approval, third, SALES.
sower
Mich bringen die Kollegen aus dem Board zum lachen so wie der Joelü aus unserem Board es tut die Meinen das der Titel zum Strong Sell bewertet werden sollte
Gruß
C.O
In regard to your first statement about written info from someone knowledgeable: No one knows Calypte better than Dr. George and Rick Brounstein. Although it's unlikely that any of us could talk directly to them. You can however check Calypte’s website and read the latest filings and news articles. I find the NR’s very informative. Plus you can listen to Conference Calls when available. I still have some of the transcripts from the most recent CC’s, they are some of the most valuable sources for me. I try to post these when someone mentions a subject that Dr. George covered, such as your question today.
Another source of info that I recommend is from readssthe10qs. I know that is going to shock some people here because most of his posts are quite negative. The reason I read his posts is because sometimes my perspective is too one sided. He knows the history of Calypte and especially its former Chairman of the Board, Tony Cataldo. As an example of why I like to read his posts - there was a question from “umpujv” #2653 about HIV’s cumulative debt. Because readssthe10qs posts are usually negative you know that if Calypte had any debt he would have found it.
As a word of caution: The yahoo board can get ugly at times so you have to let some of it roll off your back otherwise you can get cynical.
As far as the prediction of .05 cent/share: No one from the Company as far as I know has ever made that statement. The information from the CC in my post was an estimate for when the Company might be profitable. They came to that conclusion by using minimal penetration rates in China and Africa. Those sales are contingent upon government approvals.
You also mentioned production of rapid tests starting soon. Dr. George said in the November CC…
“The SFDA, because we are considered to be a Chinese company, due to our Joint Ventures, will give us what is called the “Green Light Pass” through the regulatory process. On this path, they have a regulatory requirement to respond to our application in 90 days. We’ve padded that a little, but just to give us some cushion. We are predicting that we will have an answer from the SFDA by July 1st of 2005.”
So, first the clinical results, second, SFDA approval, third, SALES.
sower
Mich bringen die Kollegen aus dem Board zum lachen so wie der Joelü aus unserem Board es tut die Meinen das der Titel zum Strong Sell bewertet werden sollte
Gruß
C.O
I've tried to estimate a projected PPS in the past. It is the million dollar question. The only way I know to do this is to look at other companies that have about the same stats that Calypte might have when sales start. Such as outstanding shares and projected income along with market cap. Some variables are impossible to calculate. You can't factor in human emotion. When sales start in China there could be a surge of buyers that push the PPS way beyond where we think possible, then again maybe not.
Let’s say Calypte’s revenue was $25M per year. That would be 8x present earnings. Should the stock price go up by 8? If it did the price would be $2.80 per share. But a company that increases it’s earnings by 8 will draw lots of attention from investors and that is the variable that is impossible to equate. Let’s say it goes to $50M per year. That’s almost 17x present earnings the price would be $6.12 per share. The time it takes to increase revenues will also be a factor, the shorter the time the higher the PPS.
If you look at OSUR, they have a market cap at $303M. It trades at 5.6x earnings, but some stocks trade at much higher multiples. A stock trading at 44x earnings is not impossible. If Calypte’s earnings were $25M and we traded at 44x earnings the price would be $5.50 per share. The PPS would double to $11.00 per share if revenue was $50M. At that price it would have a market cap of 2.2B which is inconceivable to me.
A good way to project earnings is to calculate the maximum capacity of each manufacturing plant. We know that the capacity of China and Thailand is around 100M. To use that as a guide is reasonable. I think it is very possible to achieve those figures with the present government/institutional funding and the great need for testing. We don’t know what the Rockville capacity will be. We also don’t know the profit scale for US sales in the professional and OTC markets. If the machinery is running at maximum capacity and they still can’t fill all the orders will they invest in new equipment and increase capacity to fill the demand? What about the other STD tests that Dr. George mentioned in the November CC. Some of those markets are larger than HIV/AIDS. Also, each year Calypte could gain more and more of the market for each test that’s available. These are some things to think about.
I don’t know if this helps you. It only seems makes the question bigger.
sower
Let’s say Calypte’s revenue was $25M per year. That would be 8x present earnings. Should the stock price go up by 8? If it did the price would be $2.80 per share. But a company that increases it’s earnings by 8 will draw lots of attention from investors and that is the variable that is impossible to equate. Let’s say it goes to $50M per year. That’s almost 17x present earnings the price would be $6.12 per share. The time it takes to increase revenues will also be a factor, the shorter the time the higher the PPS.
If you look at OSUR, they have a market cap at $303M. It trades at 5.6x earnings, but some stocks trade at much higher multiples. A stock trading at 44x earnings is not impossible. If Calypte’s earnings were $25M and we traded at 44x earnings the price would be $5.50 per share. The PPS would double to $11.00 per share if revenue was $50M. At that price it would have a market cap of 2.2B which is inconceivable to me.
A good way to project earnings is to calculate the maximum capacity of each manufacturing plant. We know that the capacity of China and Thailand is around 100M. To use that as a guide is reasonable. I think it is very possible to achieve those figures with the present government/institutional funding and the great need for testing. We don’t know what the Rockville capacity will be. We also don’t know the profit scale for US sales in the professional and OTC markets. If the machinery is running at maximum capacity and they still can’t fill all the orders will they invest in new equipment and increase capacity to fill the demand? What about the other STD tests that Dr. George mentioned in the November CC. Some of those markets are larger than HIV/AIDS. Also, each year Calypte could gain more and more of the market for each test that’s available. These are some things to think about.
I don’t know if this helps you. It only seems makes the question bigger.
sower
wurden ??
Was hat das zu bedeuten?
Insider Wissen ?
Kommt da das lang ersehntes?
???????????
Gruß
C.O
bringe. wie heisst es so schön: zahlen und lachen.
tja, wirklich komisch das calyptes geschäftsgebaren sogar in den usa angezweifelt und nicht nur vom dummen joelu...
tja, wirklich komisch das calyptes geschäftsgebaren sogar in den usa angezweifelt und nicht nur vom dummen joelu...
hoffnung weiter schüren, nachbörslich ging es sogar auf 0,39!
Last Change (%) After Hours Chg (%)** Trade Time Bid Ask
0.39 0.03 (8.33) 0.04 (11.43) 11:02 0 (0) 0 (0)
Last Change (%) After Hours Chg (%)** Trade Time Bid Ask
0.39 0.03 (8.33) 0.04 (11.43) 11:02 0 (0) 0 (0)
der dann plötzlich zuschlägt *g*
...ich habe mein fett schon wegbekommen von caly und schaue lieber von der außenlinie aus zu...
02/18/05 15:27:44 0.35 0.36 0.39 -463300
02/18/05 15:32:38 0.35 0.35 0.37 0§
02/18/05 15:32:47 0.36 0.36 0.37 7100§
02/18/05 15:36:42 0.37 0.36 0.37 32500§
02/18/05 15:36:46 0.37 0.36 0.38 0§
02/18/05 15:39:07 0.37 0.37 0.38 17000§
02/18/05 15:39:11 0.37 0.37 0.38§0
02/18/05 15:32:38 0.35 0.35 0.37 0§
02/18/05 15:32:47 0.36 0.36 0.37 7100§
02/18/05 15:36:42 0.37 0.36 0.37 32500§
02/18/05 15:36:46 0.37 0.36 0.38 0§
02/18/05 15:39:07 0.37 0.37 0.38 17000§
02/18/05 15:39:11 0.37 0.37 0.38§0
denn das ist klar die bessere aktie *g*
augrid ist soagr noch ein gößerer betrug als caly, darum versuche ich auch nur noch den optimalen ausstiegszeitpunkt abzupassen...im gegensatz zu euch erkenne ich aber den betrug. bei caly ist der verfall schleichender und tückischer, da immer wieder hoffnung auf besserung geweckt wird, der die interessenten bei der stange hält oder zum nachkaufen animiert.
bei augrid war es ein brutales erwachen, mit der erkenntnis, gnadenlos belogen worden zu sein...hier macht sich im gegensatz zu caly aber keiner mehr was vor. alle lauern nur noch auf die ausstiegschance.
wenn euch vor eine jahr einer gesteckt hätte, dass ihr nicht mehr die 0,40$-hürde nehmen könntet, ihr hättet es wohl nicht geglaubt.
bei den produkten und den aufträgen und den kooperationen und den experten im management und...und...und...
mittlerweile solltet ihr eigentlich mal begreifen, dass hier genauso was falsch läuft, wie bei augrid....
bei augrid war es ein brutales erwachen, mit der erkenntnis, gnadenlos belogen worden zu sein...hier macht sich im gegensatz zu caly aber keiner mehr was vor. alle lauern nur noch auf die ausstiegschance.
wenn euch vor eine jahr einer gesteckt hätte, dass ihr nicht mehr die 0,40$-hürde nehmen könntet, ihr hättet es wohl nicht geglaubt.
bei den produkten und den aufträgen und den kooperationen und den experten im management und...und...und...
mittlerweile solltet ihr eigentlich mal begreifen, dass hier genauso was falsch läuft, wie bei augrid....
bald diiiiiiiiieeeeeeeeee ausstiegsmeldung:
caly übernimmt augrid!!!! und bezahlt den kaufpreis in aktien...muhahahahhahahaaha
caly übernimmt augrid!!!! und bezahlt den kaufpreis in aktien...muhahahahhahahaaha
oder besser gesagt Taschengeld !
auch schon gut reduziert haben! und wenn du noch 1-2 jahre wartest. kommst du in augrid-regionen...
giant: das hat auch keiner gesagt, dass du das musst...
Time & Sales most recent next page
Rec. Time Action Price Volume
10:01:50 AM Ask 0.37 10200
9:56:46 AM Trade 0.37 1000
9:56:46 AM Ask 0.37 6100
9:55:20 AM Bid 0.36 25000
9:54:50 AM Ask 0.37 7100
9:54:48 AM Trade 0.37 17900
9:54:48 AM Bid 0.36 10000
9:53:58 AM Trade 0.37 25000
9:53:58 AM Bid 0.37 17900
9:41:16 AM Trade 0.37 11100
9:41:16 AM Bid 0.37 42900
9:40:42 AM Trade 0.38 1000
9:40:42 AM Ask 0.38 74400
9:40:16 AM Trade 0.38 1100
9:38:18 AM Trade 0.37 17000
9:38:18 AM Bid 0.37 54000
9:36:52 AM Bid 0.37 71000
giant: das hat auch keiner gesagt, dass du das musst...
Time & Sales most recent next page
Rec. Time Action Price Volume
10:01:50 AM Ask 0.37 10200
9:56:46 AM Trade 0.37 1000
9:56:46 AM Ask 0.37 6100
9:55:20 AM Bid 0.36 25000
9:54:50 AM Ask 0.37 7100
9:54:48 AM Trade 0.37 17900
9:54:48 AM Bid 0.36 10000
9:53:58 AM Trade 0.37 25000
9:53:58 AM Bid 0.37 17900
9:41:16 AM Trade 0.37 11100
9:41:16 AM Bid 0.37 42900
9:40:42 AM Trade 0.38 1000
9:40:42 AM Ask 0.38 74400
9:40:16 AM Trade 0.38 1100
9:38:18 AM Trade 0.37 17000
9:38:18 AM Bid 0.37 54000
9:36:52 AM Bid 0.37 71000
0,145 den Großteil gekauft aber das weist du ja
Es gibt keine neuen Beiträge.
|
WerbungPassende Knock-Outs auf Lufthansa AG
| Strategie | Hebel | |||
| Steigender Lufthansa AG-Kurs | 4,80 | 9,64 | 19,07 | |
| Fallender Lufthansa AG-Kurs | 4,74 | 10,75 | 15,55 | |
Den Basisprospekt sowie die Endgültigen Bedingungen finden Sie jeweils hier: DE000NB4AXC1
, DE000NB4MLS7
, DE000NB4ZP95
, DE000NG6PT25
, DE000NG6YFD6
, DE000NG6Y7T5
. Bitte informieren Sie sich vor Erwerb ausführlich über Funktionsweise und Risiken der Produkte. Bitte beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Neueste Beiträge aus dem Calypte Biomedical Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 97 | Wer wird der ARIVA-Trader 2003? | Happy End | ich_will | 25.04.21 10:38 | ||
3 | 153 | Der Calypte-Thread | buran | buran | 25.04.21 01:34 | |
| 6 | Calypte Biomedical, Deckel gebrochen 250% im Plus! | Börsenfan | buran | 10.06.13 23:36 | ||
| 1 | Abwarten, ist noch nicht aller Tage Abend | Volli | Volli | 25.10.11 15:49 | ||
| 2 | 49 | Calypte AIDS Studie erfolgreich 400 % WKN: 765254 | schubby1 | Volli | 30.06.11 16:36 |